Article
A Phase IV, open-label, single-arm, multicentric clinical trial for evaluation of Human Papillomavirus 9vHPV vaccine immunogenicity in Men Who Have Sex with Men living with HIV: GeSIDA Study 10017
2025-05-09
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Men who have sex with men (MSM) with HIV are at increased risk for anal cancer, largely attributable to persistent HPV infection. However, data on the nonavalent HPV vaccine (9vHPV) in MSM with HIV older than 26 remain sparse. <h4>Methods</h4> This phase IV trial evaluated the immunogenicity, safety, and impact of age and CD4/CD8 ratio on 9vHPV responses in MSM with HIV up to...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5a42e098-9d1d-50c4-8a50-bf0033466e06
- DOI
- 10.1101/2025.05.08.25327237
